Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-02-22 @ 5:41 AM
Study NCT ID:
NCT03010358
Status:
COMPLETED
Last Update Posted:
2023-08-08
First Post:
2017-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
Sponsor:
Alexey Danilov, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00016140
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None